Trading Signals: BMRN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Oct. 27, 2023)(Biomarin Pharmaceutical Inc)
| Market is closed on Wed. Nov. 29, 2023 | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 0% (three month average) | | RSI | | | Latest Price | $(0%) | | Stocks Behave Similarly | Similar Stock List | | Market Behavior | Normal for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support BMRN advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting BMRN price | BMRN will advance at least -0% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | 0% (StdDev 0%) | | Hourly BBV | 0 () | | Intraday Trend | NAN% | | | | | |
|
BioMarin Pharmaceutical, Inc. is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA. |